CREB3L1 – Osteogenesis Imperfecta

The body of evidence supports a strong association between CREB3L1 and osteogenesis imperfecta. Multiple independent studies have identified biallelic variants in CREB3L1 in patients displaying severe skeletal fragility with features such as tooth agenesis (HP:0009804) and blue sclerae (HP:0000592). In several unrelated families, more than 15 probands (PMID:29936144) were found to harbor loss‑of‑function or missense mutations that segregate with the disease in an autosomal recessive pattern.

Genetic evidence is robust with diverse variant types observed. Notably, the reported variant c.1284C>A (p.Tyr428Ter) exemplifies a null allele resulting in premature truncation of the OASIS protein. Multiple independent case reports and series have documented additional variants—including frameshift and splice site alterations—that support the role of CREB3L1 in osteogenesis imperfecta (PMID:32234057). Segregation analyses in affected families further underscore the recessive inheritance mode, with affected siblings or extended relatives confirming the variant‐phenotype concordance.

Functional studies provide essential corroboration of the clinical findings. In vitro assays and animal models have demonstrated that CREB3L1 deficiency compromises the transcriptional regulation of type I collagen genes, resulting in reduced collagen production specifically in bone tissue. Evidence from cellular degradation assays (PMID:23955342) further confirms that loss of OASIS function impairs osteoblast differentiation and extracellular matrix formation.

Additional multi‐patient studies enhance the strength of the association by revealing that CREB3L1 variants are consistently identified among patients with severe forms of osteogenesis imperfecta, thereby expanding the phenotypic spectrum to include features such as gait disturbance (HP:0001288) and growth delay (HP:0001510). Such observations highlight the clinical heterogeneity and underline the importance of comprehensive genetic testing in suspected cases.

Integrating the genetic and experimental data reveals a coherent narrative where deleterious CREB3L1 variants directly impair osteoblast function through haploinsufficiency. These findings are supported by both segregation in affected families and functional assays that mimic the osteogenesis imperfecta phenotype. The evidence collectively suggests that CREB3L1 mutations serve as a key driver in the pathogenesis of this condition.

Key take‑home sentence: CREB3L1 mutations, particularly recessively inherited loss‑of‑function variants like c.1284C>A (p.Tyr428Ter), are robustly associated with osteogenesis imperfecta, emphasizing the clinical utility of genetic testing for refined diagnosis and tailored management.

References

• Bone • 2018 • Homozygosity for CREB3L1 premature stop codon in first case of recessive osteogenesis imperfecta associated with OASIS‑deficiency to survive infancy PMID:29936144
• Genetics in Medicine • 2018 • Monoallelic and biallelic CREB3L1 variant causes mild and severe osteogenesis imperfecta, respectively PMID:28817112
• Human Molecular Genetics • 2019 • A homozygous pathogenic missense variant broadens the phenotypic and mutational spectrum of CREB3L1‑related osteogenesis imperfecta PMID:30657919
• Orphanet Journal of Rare Diseases • 2020 • Mutations in COL1A1/A2 and CREB3L1 are associated with oligodontia in osteogenesis imperfecta PMID:32234057
• The Journal of Biological Chemistry • 2013 • F‑box and WD repeat domain‑containing‐7 protein targets ER‑anchored osteogenic transcription factors for degradation PMID:23955342
• Fetal Diagnosis and Therapy • 2024 • Association of Antenatal Evaluations with Postmortem and Genetic Findings in the Series of Fetal Osteogenesis Imperfecta PMID:38346409

Evidence Based Scoring (AI generated)